Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931031 · ClinicalTrials.gov registry record
Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 40
- Enrollment target
NCT03931031 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 40 participants.
The verdict
NCT03931031 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QPlus Cartridge in patients taking anitplatelet medication that are scheduled to undergo cardiac surgery.
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2020-06-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931031
The ClinicalTrials.gov registry entry for NCT03931031 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT03931031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03931031 about?
NCT03931031 is a clinical study titled "Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery". This study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QPlus Cartridge in patients taking anitplatelet medication that are scheduled to undergo cardiac surgery.
What is the current status of trial NCT03931031?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2019-03-21. Estimated completion is 2020-06-27.
What interventions are being tested in trial NCT03931031?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03931031?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.